BGIM
CLOV icon

Boussard & Gavaudan Investment Management’s Clover Health Investments CLOV Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-500,000
Closed -$6.46M – 69
2020
Q3 		$6.46M Buy
+500,000
New +$5.53M 0.83% 14

Other funds holding CLOV

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boussard & Gavaudan Investment Management's CLOV Position: Q4 2020 in Review

Boussard & Gavaudan Investment Management sold out of Clover Health Investments (CLOV) in Q4 2020, closing a stake of 500,000 shares — an estimated $6.46M sold.

Boussard & Gavaudan Investment Management first reported a position in CLOV in Q3 2020 and held it in 1 quarter. The position peaked at $6.46M in Q3 2020. 93 funds tracked by Wall St. Rank hold CLOV as of Q4 2020.

  • Boussard & Gavaudan Investment Management reported no remaining Clover Health Investments position as of Q4 2020 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 500,000 Clover Health Investments shares in Q4 2020, an estimated $6.46M.
  • Boussard & Gavaudan Investment Management first reported a position in Clover Health Investments in Q3 2020 and held it in 1 quarter.
  • Boussard & Gavaudan Investment Management's Clover Health Investments position peaked at $6.46M in Q3 2020.
  • 93 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2020.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2020, filed 10 Feb 2021.